| Year |
Citation |
Score |
| 2022 |
Qazi MA, Salim SK, Brown KR, Mikolajewicz N, Savage N, Han H, Subapanditha MK, Bakhshinyan D, Nixon A, Vora P, Desmond K, Chokshi C, Singh M, Khoo A, Macklin A, ... ... Richards L, et al. Characterization of the minimal residual disease state reveals distinct evolutionary trajectories of human glioblastoma. Cell Reports. 40: 111420. PMID 36170831 DOI: 10.1016/j.celrep.2022.111420 |
0.549 |
|
| 2022 |
Hamed AA, Kunz DJ, El-Hamamy I, Trinh QM, Subedar OD, Richards LM, Foltz W, Bullivant G, Ware M, Vladoiu MC, Zhang J, Raj AM, Pugh TJ, Taylor MD, Teichmann SA, et al. A brain precursor atlas reveals the acquisition of developmental-like states in adult cerebral tumours. Nature Communications. 13: 4178. PMID 35853870 DOI: 10.1038/s41467-022-31408-y |
0.538 |
|
| 2021 |
Richards LM, Whitley OKN, MacLeod G, Cavalli FMG, Coutinho FJ, Jaramillo JE, Svergun N, Riverin M, Croucher DC, Kushida M, Yu K, Guilhamon P, Rastegar N, Ahmadi M, Bhatti JK, et al. Gradient of Developmental and Injury Response transcriptional states defines functional vulnerabilities underpinning glioblastoma heterogeneity. Nature Cancer. 2: 157-173. PMID 35122077 DOI: 10.1038/s43018-020-00154-9 |
0.614 |
|
| 2021 |
Croucher DC, Richards LM, Tsofack SP, Waller D, Li Z, Wei EN, Huang XF, Chesi M, Bergsagel PL, Sebag M, Pugh TJ, Trudel S. Longitudinal single-cell analysis of a myeloma mouse model identifies subclonal molecular programs associated with progression. Nature Communications. 12: 6322. PMID 34732728 DOI: 10.1038/s41467-021-26598-w |
0.622 |
|
| 2021 |
Pryszlak M, Wiggans M, Chen X, Jaramillo JE, Burns SE, Richards LM, Pugh TJ, Kaplan DR, Huang X, Dirks PB, Pearson BJ. The DEAD-box helicase DDX56 is a conserved stemness regulator in normal and cancer stem cells. Cell Reports. 34: 108903. PMID 33789112 DOI: 10.1016/j.celrep.2021.108903 |
0.552 |
|
| 2021 |
Sachamitr P, Ho JC, Ciamponi FE, Ba-Alawi W, Coutinho FJ, Guilhamon P, Kushida MM, Cavalli FMG, Lee L, Rastegar N, Vu V, Sánchez-Osuna M, Coulombe-Huntington J, Kanshin E, Whetstone H, ... ... Richards LM, et al. PRMT5 inhibition disrupts splicing and stemness in glioblastoma. Nature Communications. 12: 979. PMID 33579912 DOI: 10.1038/s41467-021-21204-5 |
0.551 |
|
| 2020 |
Restall IJ, Cseh O, Richards LM, Pugh TJ, Luchman HA, Weiss S. Brain tumor stem cell dependence on glutaminase reveals a metabolic vulnerability through the amino acid deprivation response pathway. Cancer Research. PMID 33106333 DOI: 10.1158/0008-5472.CAN-19-3923 |
0.548 |
|
| 2020 |
Manoranjan B, Venugopal C, Bakhshinyan D, Adile AA, Richards L, Kameda-Smith MM, Whitley O, Dvorkin-Gheva A, Subapanditha M, Savage N, Tatari N, McKenna D, Bassey-Archibong B, Winegarden N, Hallett R, et al. Wnt activation as a therapeutic strategy in medulloblastoma. Nature Communications. 11: 4323. PMID 32859895 DOI: 10.1038/S41467-020-17953-4 |
0.495 |
|
| 2020 |
Mohanraj S, Díaz-Mejía JJ, Pham MD, Elrick H, Husić M, Rashid S, Luo P, Bal P, Lu K, Patel S, Mahalanabis A, Naidas A, Christensen E, Croucher D, Richards LM, et al. CReSCENT: CanceR Single Cell ExpressioN Toolkit. Nucleic Acids Research. PMID 32479601 DOI: 10.1093/Nar/Gkaa437 |
0.608 |
|
| 2017 |
Lan X, Jörg DJ, Cavalli FMG, Richards LM, Nguyen LV, Vanner RJ, Guilhamon P, Lee L, Kushida MM, Pellacani D, Park NI, Coutinho FJ, Whetstone H, Selvadurai HJ, Che C, et al. Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy. Nature. PMID 28854171 DOI: 10.1038/Nature23666 |
0.566 |
|
| Show low-probability matches. |